The Medical Affairs Essentials Summer School is a unique chance for professionals in this increasingly important function to both deepen and broaden their skills and abilities in the areas of KOL communication, stakeholder engagement, late-phase study development and implementation, as well as to demonstrate the value of a product in clinical, but also economic terms.
The 2 day course will be run as a series of 4 x half-day workshops, led by expert consultants and experienced industry representatives. The concept is to give medical affairs team members a condensed set of training to bring them up to the highest standard or as a refresher for those looking to implement best practices in medical affairs. All training will be focused on real-world scenarios and challenges specific to their roles, from experienced practitioners. All workshops will be in 50% didactic/presentation-style and 50% interactive sessions (small groups syndicates & real-world scenarios).
Medical affairs and MSL executives are increasingly being expected to improve their capabilities, in line with the medical affairs department’s increasingly central role in the Pharmaceutical or MedTech organization. Medical affairs and liaisons need to deepen their ability to communicate and engage with KOLs, external experts and other stakeholders and this increasingly requires more powerful “soft skills” such as communication and persuasion. Furthermore, in terms of written communication, medical writing skills are as important as ever and working closely with KOLs and investigators to produce interesting publications that appeal to a broad audience is key. Medical affairs professionals also need to improve their technical expertise in areas like late-phase trial design and the implementation of real-world, observational studies, to maximize the opportunity to capture essential evidence of product value. Furthermore, when developing late-phase evidence, medical affairs now need to work more closely with market access and health economic teams to understand what data they require in order to satisfy payers who make decisions based on the economic value of a therapy. The cost and budgetary-effectiveness of a drug or device also increasingly needs to be communicated to external experts and prescribers. This compact, 2-day training and refresher course will enable all participants with the fundamentals to carry out their Medical Affairs activities at the standard of today’s “best practices”.
Tardis Medical Consultancy (Publicis Healthcare Communications Group)
Succinct Medical Communications (an OPEN Health Company)
Vice President & Head, Pricing & Market Access
Vice President & Global Head, Observational Research,
This event will provide all delegates the chance to meet one another through our many networking opportunities. With pre-event, mid-morning and mid-afternoon breaks as a standard, this event will also feature a complimentary networking dinner for all participants.
This evening will allow you to meet with our expert speaker panel who represent many stakeholder groups in a less formal setting. Our networking lunches will also allow you plenty of time to meet with your peers and colleagues whilst you refuel through the event.